Mode of Induction in Fetal Growth Restriction and Its Affects on Fetal and Maternal Outcomes
Launched by TEL-AVIV SOURASKY MEDICAL CENTER · Aug 9, 2018
Trial Information
Current as of July 04, 2025
Unknown status
Keywords
ClinConnect Summary
Intra uterine growth restriction (FGR) is a condition in which the fetus does not realize its growth potential in uterus. The excepted definitions of this condition are fetal weight estimation below the 10th percentile per gestational week. Severe growth restriction is defined as estimated weight below the 3rd percentile. It is well known that fetuses which are growth restricted are subjected to a higher degree of complications during pregnancy and delivery such as fetal distress, hypoxic damage, intra uterine fetal demise and complications in the neonatal period including prolonged NICU ho...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • singleton pregnancy
- • fetal growth restriction defined as estimated fetal weight between the 3rd and 10th percentile per gestational age and are intended to deliver vaginally
- • Gestational age between 36 and 42 weeks
- • No known fetal anomalies
- Exclusion Criteria:
- • Fetal estimated weight below the 3rd percentile
- • Known fetal anomalies
- • Contraindications for vaginal delivery: breech presentation, abnormal Doppler flow velocimetry of fetal ductus venosus.
- • Oligohydramnios defined as amniotic fluid index below 5 cm
- • Contraindication to the use of prostaglandins
- • Fetal distress requiring emergent cesarean section
- • All other condition preventing vaginal delivery as decided by a senior physician
About Tel Aviv Sourasky Medical Center
Tel Aviv Sourasky Medical Center, a leading academic medical institution in Israel, is renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a multidisciplinary approach, the center integrates cutting-edge medical technology and evidence-based practices to enhance patient care and outcomes. Its robust infrastructure supports a diverse range of clinical studies, fostering collaboration among healthcare professionals, researchers, and industry partners. The center's dedication to research excellence and patient safety positions it as a key player in the global clinical research landscape, driving advancements in medical knowledge and treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tel Aviv, , Israel
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials